Aviva
VCYT icon

Aviva’s Veracyte VCYT Stock Holding History

Aviva’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,736
Closed -$1.33M – 980
2021
Q1 		$1.33M Sell
24,736
-15,159
-38% -$873K 0.01% 744
2020
Q4 		$1.95M Sell
39,895
-32,340
-45% -$1.5M 0.01% 679
2020
Q3 		$2.35M Sell
72,235
-21,174
-23% -$673K 0.01% 653
2020
Q2 		$2.42M Sell
93,409
-66,746
-42% -$1.66M 0.02% 583
2020
Q1 		$3.89M Buy
+160,155
New +$4.03M 0.03% 470

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aviva's VCYT Position: Q2 2021 in Review

Aviva sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 24,736 shares — an estimated $1.33M sold.

Aviva first reported a position in VCYT in Q1 2020 and held it in 5 quarters. The position peaked at $3.89M in Q1 2020. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Aviva reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Aviva sold 24,736 Veracyte shares in Q2 2021, an estimated $1.33M.
  • Aviva first reported a position in Veracyte in Q1 2020 and held it in 5 quarters.
  • Aviva's Veracyte position peaked at $3.89M in Q1 2020.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.